Parse Biosciences Expands Nordic Reach with Xpress Genomics CSP Partnership
Event summary
- Parse Biosciences adds Xpress Genomics as its first Nordic Certified Service Provider (CSP) on July 29, 2026.
- Xpress Genomics will offer Parse's Evercode single cell sequencing portfolio through its existing service pipeline.
- Founded in 2022 by Karolinska Institutet researchers, Xpress Genomics specializes in automated NGS workflows.
The big picture
Parse Biosciences continues its strategic expansion through partnerships, reinforcing its position in the scalable single-cell sequencing market. The addition of Xpress Genomics as a CSP extends Parse's reach into the Nordic region, where demand for advanced genomic research tools is growing. This move aligns with broader industry trends toward regional specialization and technological collaboration to enhance research capabilities.
What we're watching
- Market Penetration
- Whether Parse can leverage Xpress Genomics to capture significant market share in the Nordic single-cell sequencing space.
- Technological Integration
- How seamlessly Evercode technology integrates with Xpress Genomics' existing high-throughput sequencing workflows.
- Competitive Dynamics
- The pace at which other single-cell sequencing providers respond to Parse's expanded Nordic presence.
Related topics